Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Aditi Mehta
Advertisement
Aditi Mehta is an associate director, mRNA process and delivery, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles by Aditi Mehta
Advertisement
Latest Updated Articles
- Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Published: October 7th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
